Health Care · Surgical & Medical Instruments & Apparatus · NYSE · CIK 96943 · FYE Dec 31 · Prices AT CLOSE 2026-07-30 (USD) — end-of-day, never a live or intraday quote
Last $132.30Day −1.75%Mkt cap $6.0B1Y +17.5%Off 52W high −5.3%Vol (1Y) 40.9%
Daily closing price, split-adjusted to the current basis; 3y shown of 5,296 bars on file. Sampled to 240 points — every point is a real close, none averaged. Price return, not total return (dividends excluded). Source marketstack.
| Price impliesHEROIC · 26.5% growth |
| Short interest6.3% of sh out |
| Days to cover6.2d |
| 13F net flow (QoQ)−16.34% |
| Top-10 13F concentration52.5% |
| Next report (est.)2026-08-06 |
Fair value, confidence and the reverse-DCF grade are the MATERIALIZED daily snapshot (the same columns the screener serves), not a live model run. Short interest is FINRA semi-monthly, settlement 2026-07-15. 13F figures are quarterly filings, period 2026-Q1 — a lower bound on true ownership.
| Sales (TTM)$2.13B |
| Earnings (TTM)-$1.01B |
| ROE−24.5% |
| Net margin−45.4% |
| ROIC2.1% |
| Debt / equity0.85× |
| YTD+9.0% |
| 1Y+17.5% |
| 3Y−45.8% |
| 5Y−65.4% |
| 10Y−21.8% |
| Since incept. (ann.)+5.2% |
Total return through 2026-07-30 · series begins 2005-07-07. Only the windows this history actually covers are shown.
| Ann. volatility (1Y)40.9% |
| Ann. volatility (3Y)36.0% |
| Sharpe (1Y)0.57 |
| Sharpe (3Y)−0.39 |
| Max drawdown (1Y)−24.4% |
| Max drawdown (3Y)−60.1% |
| Beta (3Y vs SPY)0.80 |
Daily simple returns, annualized; drawdown is peak-to-trough within the window. Beta is the OLS slope of monthly returns on SPY's over three years. Each figure is labeled by the window it was measured over — they are not comparable across windows.
| Manager | Shares | Value | % sh out | QoQ |
|---|---|---|---|---|
| BlackRock, Inc. | 5.4M | $645M | — | +1.0% |
| JANUS HENDERSON GROUP PLC | 4.3M | $513M | — | +1.1% |
| T. Rowe Price Investment Management, Inc. | 3.8M | $459M | — | −46.7% |
| VANGUARD PORTFOLIO MANAGEMENT LLC | 2.4M | $292M | — | new |
| VANGUARD CAPITAL MANAGEMENT LLC | 2.0M | $237M | — | new |
| BAUPOST GROUP LLC/MA | 1.6M | $191M | — | new |
| Sessa Capital IM, L.P. | 1.5M | $183M | — | new |
| STATE STREET CORP | 1.5M | $180M | — | +1.6% |
Reported 13F long positions as filed for 2026-Q1 (change vs 2025-Q4). 13F covers US-listed long equity only — the sum is a LOWER BOUND on institutional ownership, never a total. % of shares outstanding suppressed: the summed institutional 13F holdings (47,842,006) exceed the cover-page shares-outstanding count for this quarter (44,200,562, as of 2026-02-25) by more than securities-lending double counting can explain (FINRA short interest 2,159,894 shares at 2026-04-30), so the share count is stale or wrong (common for annual 20-F foreign private issuers after a share issuance) and a percentage would be fabricated. Holder share counts are shown as filed.
| Period end | Reported | EPS | EPS YoY | Revenue | Rev YoY |
|---|---|---|---|---|---|
| 2026-03-31 | 2026-05-07 | −$0.18 | −108.7% | $548.3M | +32.3% |
| 2025-12-31 | 2026-02-26 | −$16.15 | — | $569.0M | +28.7% |
| 2025-09-28 | 2025-11-06 | −$9.24 | −491.5% | $566.9M | +33.0% |
| 2025-06-29 | 2025-07-31 | $2.77 | +63.9% | $442.5M | +5.7% |
EPS and revenue as reported in this filer's own XBRL — our extraction of the filings, not a vendor consensus feed, and never a beat/miss claim (we carry no estimates). YoY compares the same fiscal quarter a year earlier. Next report 2026-08-06 is ESTIMATED from filing cadence (median gap 91d) — not company-confirmed.
Americas 64% · EMEA 24% · Asia 12%
business segments · each slice's share of TAGGED segment revenue in the latest annual filing (XBRL, as filed). Untagged revenue is excluded from the denominator, so slices need not sum to consolidated sales.
| Total debt / EBITDA8.92× |
| Sales growth 3Y−10.6% |
Screener basis: ratios from the latest reported fiscal year; Sales/Earnings are trailing twelve months in the reporting currency (USD). The P/E is a trailing FULL-YEAR P/E, not TTM. Missing lines are absent from the filings, never imputed.
